Last updated on September 2012

GOG 0275: A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-Day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia


Brief description of study

GOG 0275: A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-Day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01535053?term=GOG+0275&rank=1

Clinical Study Identifier: TX136228

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patricia Green

Memorial University Medical Center
Savannah, GA USA
  Connect »